Clinical Trials Browser

Phase 2/3 × Hematologic Neoplasms × thymoglobulin × Clear all

NCT03818334 2019-02-01

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Phase 2/3 Recruiting

Other hematologic neoplasm

Graft vs Host Disease, Virus Diseases, Hematologic Neoplasms